SMA drug risdiplam shows nerve repair promise in new study
Knowledge-focused
Completed
This study looked at 18 adults with spinal muscular atrophy (SMA) who had taken the oral medication risdiplam for at least one year. Researchers measured how well nerves and muscles communicate using electrical tests and walking tests. The goal was to see if risdiplam improves ne…
Sponsor: Bakri Elsheikh • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC